Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib / 한국유방암학회지
Journal of Breast Cancer
;
: 100-106, 2020.
Artículo
en Inglés
| WPRIM
| ID: wpr-811192
ABSTRACT
Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia. However, hematological malignancies have not been reported for palbociclib treatment. Here, for the first time, we present a case of acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment with letrozole and palbociclib for metastatic breast cancer. This case emphasizes the need for long term follow up of patients treated with palbociclib.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias de la Mama
/
Estudios de Seguimiento
/
Neoplasias Hematológicas
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
Leucopenia
/
Neutropenia
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
/
Factores de riesgo
Límite:
Humanos
Idioma:
Inglés
Revista:
Journal of Breast Cancer
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS